LUNGevity Foundation Welcomes Corporate Executive Board As National Sponsor
Nation's largest lung cancer-focused nonprofit receives 2012 CEB Community Investment Grant to help stop lung cancer
WASHINGTON, March 22, 2012 /PRNewswire-USNewswire/ -- LUNGevity Foundation is pleased to announce Corporate Executive Board (CEB), an Arlington, Va. based leading research and advisory services firm, as one of its 2012 National Sponsors. As a National Sponsor, CEB helps LUNGevity in its quest to fund life saving research for treatments and cures for the nation's number one cancer killer, providing resources and helping build a community for those impacted by the disease.
As a recent recipient of the 2012 CEB Community Investment Grant, which serves to advance entrepreneurship, innovation and community building in cities and countries in need around the world, LUNGevity has entered into a relationship with CEB which includes both financial and in-kind support. In addition, LUNGevity is pleased to have the support of CEB volunteers.
"LUNGevity is honored to be a recipient of one of the 2012 CEB Community Investment Grants and welcome the company as a 2012 National Sponsor," said LUNGevity Foundation President Andrea Stern Ferris. "We've enjoyed a long standing, supportive relationship with CEB, and are excited to enter into this new phase. The support of companies like CEB is invaluable in our quest to start a national conversation about lung cancer and save lives.""Our first connection to LUNGevity was through Breathe Deep DC in 2009. Since then, the Foundation has continued to grow dramatically, and we are pleased to play a part in that success. This year, as a National Sponsor, we are looking forward to having our staff become involved in more LUNGevity events around the country," said Tom Monahan, CEB Chairman and CEO. "We are proud to join Pfizer as a LUNGevity national partner and encourage other companies to support the organization's efforts to cure lung cancer." About LUNGevity Foundation The mission of LUNGevity Foundation is to have a meaningful impact on improving lung cancer survival rates, ensure a higher quality of life for lung cancer patients, and provide a community for those impacted by lung cancer.
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts